# FDA Inspection 1050820 - Ian W Flinn MD, Ph D - April 20, 2018

Source: https://www.keypedia.com/records/fda_inspections/ian-w-flinn-md-ph-d/0a4d01f2-ab49-47f3-bbde-6e58e62fe05b
Source feed: FDA_Inspections

> FDA Inspection 1050820 for Ian W Flinn MD, Ph D on April 20, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050820
- Company Name: Ian W Flinn MD, Ph D
- Inspection Date: 2018-04-20
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1146998 - 2021-07-02](https://www.keypedia.com/records/fda_inspections/ian-w-flinn-md-ph-d/0c0f9c48-d03d-420f-b59d-847c59e28e9b)
- [FDA Inspection 663182 - 2010-05-21](https://www.keypedia.com/records/fda_inspections/ian-w-flinn-md-ph-d/e5a8547f-4eaf-42ea-90d5-ff387041e883)

Company: https://www.keypedia.com/companies/ian-w-flinn-md-ph-d/4dc38856-e8bd-4b2e-9a7f-6f38ceea662a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c